Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Oh cystinosin: let me count the ways!

Langman CB.

Kidney Int. 2019 Aug;96(2):275-277. doi: 10.1016/j.kint.2019.05.016.

PMID:
31331465
2.

Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy.

Okuda Y, Obi Y, Streja E, Laster M, Rhee C, Langman CB, Jernigan SM, Salusky IB, Tentori F, Schreiber MJ, Brunelli SM, Kalantar-Zadeh K.

Pediatr Nephrol. 2019 Jun 19. doi: 10.1007/s00467-019-04270-2. [Epub ahead of print]

PMID:
31218394
3.

Metabolomic Patterns in Adolescents With Mild to Moderate CKD.

Brooks ER, Lin DC, Langman CB, Thompson JW, St John-Williams L, Furth SL, Warady B, Haymond S.

Kidney Int Rep. 2019 Jan 28;4(5):720-723. doi: 10.1016/j.ekir.2019.01.009. eCollection 2019 May. No abstract available.

4.

ALLN-177, oral enzyme therapy for hyperoxaluria.

Lingeman JE, Pareek G, Easter L, Pease R, Grujic D, Brettman L, Langman CB.

Int Urol Nephrol. 2019 Apr;51(4):601-608. doi: 10.1007/s11255-019-02098-1. Epub 2019 Feb 19.

5.

Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.

Onder AM, Flynn JT, Billings AA, Deng F, DeFreitas M, Katsoufis C, Grinsell MM, Patterson LT, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L, Ellis E, Chadha V, Elmaghrabi A, Lin JJ, Butani L, Haddad M, Couloures OM, Brakeman P, Quigley R, Shin HS, Garro R, Liu H, Rahimikollu J, Raina R, Langman CB, Wood EG; Midwest Pediatric Nephrology Consortium.

Pediatr Nephrol. 2019 Aug;34(8):1483-1484. doi: 10.1007/s00467-019-4199-0.

PMID:
30684015
6.

Autonomic Nervous System Dysregulation in Monozygous Twins With Nephropathic Cystinosis.

Brooks ER, Deng F, Weese-Mayer DE, Kuntz NL, Langman CB.

Kidney Int Rep. 2018 Jul 29;3(6):1489-1496. doi: 10.1016/j.ekir.2018.07.019. eCollection 2018 Nov. No abstract available.

7.

Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.

Laster M, Soohoo M, Streja E, Elashoff R, Jernigan S, Langman CB, Norris KC, Salusky IB, Kalantar-Zadeh K.

Pediatr Nephrol. 2019 Jan;34(1):107-115. doi: 10.1007/s00467-018-4048-6. Epub 2018 Sep 29.

PMID:
30267239
8.

Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.

Onder AM, Flynn JT, Billings AA, Deng F, DeFreitas M, Katsoufis C, Grinsell MM, Patterson LT, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L, Ellis E, Chanda V, Elmaghrabi A, Lin JJ, Butani L, Haddad M, Couloures OM, Brakeman P, Quigley R, Stella Shin H, Garro R, Liu H, Rahimikollu J, Raina R, Langman CB, Wood EG; Midwest Pediatric Nephrology Consortium.

Pediatr Nephrol. 2019 Feb;34(2):329-339. doi: 10.1007/s00467-018-4082-4. Epub 2018 Sep 27. Erratum in: Pediatr Nephrol. 2019 Jan 25;:.

PMID:
30264215
9.

Hypocitraturia Is an Untoward Side Effect of Synthetic Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal Morbidity.

Gafni RI, Langman CB, Guthrie LC, Brillante BA, James R, Yovetich NA, Boyce AM, Collins MT.

J Bone Miner Res. 2018 Oct;33(10):1741-1747. doi: 10.1002/jbmr.3480. Epub 2018 Jun 22.

PMID:
29878514
10.

Associations of osteoprotegerin with coronary artery calcification among women with systemic lupus erythematosus and healthy controls.

Poornima IG, Shields K, Kuller LH, Manzi SM, Ramsey-Goldman R, Richardson C, Rhew E, Dunlop DD, Song J, Edmundowicz D, Kondos GT, Carr JJ, Langman CB, Price H, Chung AH, Santelices LB, Mackey RH.

Lupus. 2018 Jan 1:961203317751060. doi: 10.1177/0961203317751060. [Epub ahead of print]

11.

A rational approach to the use of sophisticated genetic analyses of pediatric stone disease.

Langman CB.

Kidney Int. 2018 Jan;93(1):15-18. doi: 10.1016/j.kint.2017.08.023.

PMID:
29291816
12.

Contribution of symmetric dimethylarginine to GFR decline in pediatric chronic kidney disease.

Brooks ER, Haymond S, Rademaker A, Pierce C, Helenowski I, Passman R, Vicente F, Warady BA, Furth SL, Langman CB.

Pediatr Nephrol. 2018 Apr;33(4):697-704. doi: 10.1007/s00467-017-3842-x. Epub 2017 Dec 7.

PMID:
29214443
13.

Analyte variations in consecutive 24-hour urine collections in children.

Ellison JS, Hollingsworth JM, Langman CB, Asplin JR, Schwaderer AL, Yan P, Bierlein M, Barraza MA, Defoor WR, Figueroa TE, Jackson EC, Jayanthi VR, Johnson EK, Joseph DB, Shnorhavorian M.

J Pediatr Urol. 2017 Dec;13(6):632.e1-632.e7. doi: 10.1016/j.jpurol.2017.06.014. Epub 2017 Jul 12.

PMID:
28739373
14.

Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males.

Falkner B, Keith SW, Gidding SS, Langman CB.

J Am Soc Hypertens. 2017 Aug;11(8):480-487. doi: 10.1016/j.jash.2017.04.001. Epub 2017 Apr 12.

15.

Race, obesity, and the renin-angiotensin-aldosterone system: treatment response in children with primary hypertension.

South AM, Arguelles L, Finer G, Langman CB.

Pediatr Nephrol. 2017 Sep;32(9):1585-1594. doi: 10.1007/s00467-017-3665-9. Epub 2017 Apr 14.

PMID:
28411317
16.

Bone Complications of Cystinosis.

Langman CB.

J Pediatr. 2017 Apr;183S:S2-S4. doi: 10.1016/j.jpeds.2016.12.052. No abstract available.

PMID:
28343472
17.

Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia.

Nampoothiri S, Fernández-Rebollo E, Yesodharan D, Gardella TJ, Rush ET, Langman CB, Jüppner H.

J Clin Endocrinol Metab. 2016 Nov;101(11):4283-4289. Epub 2016 Jul 13.

18.

A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.

Langman CB, Grujic D, Pease RM, Easter L, Nezzer J, Margolin A, Brettman L.

Am J Nephrol. 2016;44(2):150-8. doi: 10.1159/000448766. Epub 2016 Aug 17.

19.

Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation.

Liu Y, Weisberg LS, Langman CB, Logan A, Hunter K, Prasad D, Avila J, Venkatchalam T, Berns JS, Handelman GJ, Sirover WD.

Clin Biochem. 2016 Oct;49(15):1133-1139. doi: 10.1016/j.clinbiochem.2016.05.025. Epub 2016 Jun 3.

PMID:
27265723
20.

Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Langman CB, Barshop BA, Deschênes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servais A, Soliman NA, Thoene JG, Levtchenko EN; Conference Participants.

Kidney Int. 2016 Jun;89(6):1192-203. doi: 10.1016/j.kint.2016.01.033.

PMID:
27181776
21.

Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.

Brooks ER, Hoppe B, Milliner DS, Salido E, Rim J, Krevitt LM, Olson JB, Price HE, Vural G, Langman CB.

Am J Nephrol. 2016;43(4):293-303. doi: 10.1159/000445448. Epub 2016 May 3.

22.

Complement and the kidney in the setting of Shiga-toxin hemolytic uremic syndrome, organ transplantation, and C3 glomerulonephritis.

Keir LS, Langman CB.

Transfus Apher Sci. 2016 Apr;54(2):203-11. doi: 10.1016/j.transci.2016.04.010. Epub 2016 Apr 25. Review.

PMID:
27156109
23.

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome.

Palma LM, Langman CB.

J Blood Med. 2016 Apr 12;7:39-72. doi: 10.2147/JBM.S36249. eCollection 2016. Review.

24.

Maternal BMI Associations with Maternal and Cord Blood Vitamin D Levels in a North American Subset of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Participants.

Josefson JL, Reisetter A, Scholtens DM, Price HE, Metzger BE, Langman CB; HAPO Study Cooperative Research Group.

PLoS One. 2016 Mar 4;11(3):e0150221. doi: 10.1371/journal.pone.0150221. eCollection 2016. Erratum in: PLoS One. 2016;11(4):e0153339.

25.

Vitamin D Insufficiency and Fracture Risk in Urban Children.

Thompson RM, Dean DM, Goldberg S, Kwasny MJ, Langman CB, Janicki JA.

J Pediatr Orthop. 2017 Sep;37(6):368-373. doi: 10.1097/BPO.0000000000000697.

PMID:
26600296
26.

A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.

Hoover KB, Miller CG, Galante NC, Langman CB.

Osteoporos Int. 2015 Oct;26(10):2441-7. doi: 10.1007/s00198-015-3158-2. Epub 2015 May 9.

PMID:
25956286
27.

An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V; HUS International.

Pediatr Nephrol. 2016 Jan;31(1):15-39. doi: 10.1007/s00467-015-3076-8. Epub 2015 Apr 11. Review.

PMID:
25859752
28.

Applicability of estimating glomerular filtration rate equations in pediatric patients: comparison with a measured glomerular filtration rate by iohexol clearance.

Deng F, Finer G, Haymond S, Brooks E, Langman CB.

Transl Res. 2015 Mar;165(3):437-45. doi: 10.1016/j.trsl.2014.10.004. Epub 2014 Oct 14.

29.

Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.

Ali FN, Falkner B, Gidding SS, Price HE, Keith SW, Langman CB.

J Pediatr. 2014 Oct;165(4):738-43.e1. doi: 10.1016/j.jpeds.2014.06.027. Epub 2014 Jul 22.

30.

Medication adherence and growth in children with CKD.

Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, Furth SL, Moxey-Mims M, Warady BA, Kaskel FJ, Skversky AL.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1519-25. doi: 10.2215/CJN.01150114. Epub 2014 Jun 26.

31.

Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate.

Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, Cornelissen EA, Morin D, Cochat P, Elenberg E, Hanna C, Gaillard S, Bagger MJ, Rioux P.

J Pediatr. 2014 Sep;165(3):528-33.e1. doi: 10.1016/j.jpeds.2014.05.013. Epub 2014 Jun 16.

32.

Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.

Finer G, Price HE, Shore RM, White KE, Langman CB.

Am J Med Genet A. 2014 Jun;164A(6):1545-9. doi: 10.1002/ajmg.a.36476. Epub 2014 Mar 25.

PMID:
24668887
33.

Defining variation in urinary oxalate in hyperoxaluric stone formers.

Antonelli JA, Langman CB, Odom C, Poindexter J, Huet B, Pearle MS.

J Endourol. 2013 Dec;27(12):1530-4. doi: 10.1089/end.2013.0199. Epub 2013 Oct 22.

PMID:
24147733
34.

Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.

Edwards BJ, Usmani S, Raisch DW, McKoy JM, Samaras AT, Belknap SM, Trifilio SM, Hahr A, Bunta AD, Abu-Alfa A, Langman CB, Rosen ST, West DP.

J Oncol Pract. 2013 Mar;9(2):101-6. doi: 10.1200/JOP.2011.000486.

35.

Longitudinal trajectory of vitamin D status from birth to early childhood in the development of food sensitization.

Liu X, Arguelles L, Zhou Y, Wang G, Chen Q, Tsai HJ, Hong X, Liu R, Price HE, Pearson C, Apollon S, Cruz N, Schleimer R, Langman CB, Pongracic JA, Wang X.

Pediatr Res. 2013 Sep;74(3):321-6. doi: 10.1038/pr.2013.110. Epub 2013 Jun 24.

36.

Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Bock ME, Price HE, Gallon L, Langman CB.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1304-11. doi: 10.2215/CJN.07680712. Epub 2013 Apr 25.

37.

Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations.

Jaureguiberry G, De la Dure-Molla M, Parry D, Quentric M, Himmerkus N, Koike T, Poulter J, Klootwijk E, Robinette SL, Howie AJ, Patel V, Figueres ML, Stanescu HC, Issler N, Nicholson JK, Bockenhauer D, Laing C, Walsh SB, McCredie DA, Povey S, Asselin A, Picard A, Coulomb A, Medlar AJ, Bailleul-Forestier I, Verloes A, Le Caignec C, Roussey G, Guiol J, Isidor B, Logan C, Shore R, Johnson C, Inglehearn C, Al-Bahlani S, Schmittbuhl M, Clauss F, Huckert M, Laugel V, Ginglinger E, Pajarola S, Spartà G, Bartholdi D, Rauch A, Addor MC, Yamaguti PM, Safatle HP, Acevedo AC, Martelli-Júnior H, dos Santos Netos PE, Coletta RD, Gruessel S, Sandmann C, Ruehmann D, Langman CB, Scheinman SJ, Ozdemir-Ozenen D, Hart TC, Hart PS, Neugebauer U, Schlatter E, Houillier P, Gahl WA, Vikkula M, Bloch-Zupan A, Bleich M, Kitagawa H, Unwin RJ, Mighell A, Berdal A, Kleta R.

Nephron Physiol. 2012;122(1-2):1-6. doi: 10.1159/000349989. Epub 2013 Feb 23.

38.

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH.

J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181. Review.

39.

Preoperative plasma FGF23 levels predict acute kidney injury in children: results of a pilot study.

Ali FN, Hassinger A, Price H, Langman CB.

Pediatr Nephrol. 2013 Jun;28(6):959-62. doi: 10.1007/s00467-012-2395-2. Epub 2013 Jan 13.

PMID:
23314442
40.

Maternal obesity and vitamin D sufficiency are associated with cord blood vitamin D insufficiency.

Josefson JL, Feinglass J, Rademaker AW, Metzger BE, Zeiss DM, Price HE, Langman CB.

J Clin Endocrinol Metab. 2013 Jan;98(1):114-9. doi: 10.1210/jc.2012-2882. Epub 2012 Nov 8.

41.

Obstructive uropathy is associated with polyomavirus viremia in pediatric kidney transplantation.

Matossian D, Langman CB, Cohn RA, Ali FN.

Pediatr Transplant. 2012 Nov;16(7):729-34. doi: 10.1111/j.1399-3046.2012.01732.x. Epub 2012 Jun 7.

PMID:
22676554
42.

An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.

Padhi D, Langman CB, Fathallah-Shaykh S, Warady BA, Salusky IB, Lee E, Wang C, Posvar E.

Pediatr Nephrol. 2012 Oct;27(10):1953-9. doi: 10.1007/s00467-012-2186-9. Epub 2012 May 26.

43.

A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.

Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1112-20. doi: 10.2215/CJN.12321211. Epub 2012 May 3. Erratum in: Clin J Am Soc Nephrol. 2013 Mar 7;8(3):468.

44.

Clinical grand rounds: atypical hemolytic uremic syndrome.

Hodgkins KS, Bobrowski AE, Lane JC, Langman CB.

Am J Nephrol. 2012;35(5):394-400. doi: 10.1159/000337954. Epub 2012 Apr 18.

45.

Pediatrics: Measuring pediatric BMD-the bar raised but the glass half full.

Langman CB.

Nat Rev Endocrinol. 2011 Nov 22;8(1):5-6. doi: 10.1038/nrendo.2011.205.

PMID:
22105020
46.

Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.

Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, Xu X, Wang X.

Clin J Am Soc Nephrol. 2011 Mar;6(3):482-8. doi: 10.2215/CJN.05310610. Epub 2010 Nov 18.

47.

Transplantation outcomes in primary hyperoxaluria.

Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, Milliner DS; IPHR Investigators.

Am J Transplant. 2010 Nov;10(11):2493-501. doi: 10.1111/j.1600-6143.2010.03271.x. Epub 2010 Sep 17.

48.

Oral phosphate binders in patients with kidney failure.

Moe SM, Block GA, Langman CB.

N Engl J Med. 2010 Sep 2;363(10):990; author reply 990. doi: 10.1056/NEJMc1005274. No abstract available.

PMID:
20830820
49.

Dose of dialysis based on body surface area is markedly less in younger children than in older adolescents.

Daugirdas JT, Hanna MG, Becker-Cohen R, Langman CB.

Clin J Am Soc Nephrol. 2010 May;5(5):821-7. doi: 10.2215/CJN.08171109. Epub 2010 Mar 18.

50.

Calcium in chronic kidney disease: myths and realities. Introduction.

Langman CB, Cannata-Andía JB.

Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S1-2. doi: 10.2215/CJN.06140809. No abstract available.

Supplemental Content

Loading ...
Support Center